Monitoring of urinary microbiota and uropathogens' antibiotic resistance in one urological hospital

Introduction. There is no consensus on the management of patients with recurrent uncomplicated lower urinary tract infection (uLUTI), which makes it difficult to carry out effective therapy.

Purpose of the study. To study the microbial patterns of urine and uropathogens' antibiotic resistance in a urological hospital from 2010 to 2017.

Materials and methods. The results of bacteriological studies and the data of individual antibiotic susceptibility testing of patients with recurrent uLUTI (n = 502) were retrospectively analyzed. Inclusion criteria of the study: consent of patients to participate in the study, the presence of clinical manifestations of recurrent uLUTI in anamnesis, two episodes within six months or three during the year, leukocyturia in the urinalysis, the absence of sexually transmitted diseases at the time of the study and in anamnesis and also vaginal discharge. Bacteriological studies of the midstream morning urine sample before the prescription of antibiotic therapy were carried out with the determination of antibiotic sensitivity/resistance and production of extended-spectrum p-lactamases. In addition to the standard set of culture media, chromogenic media, aerobic and anaerobic culturing conditions were used. Statistical analysis was performed in the statistical processing and data visualization environment «R ver 3.2» («R Foundation for Statistical Computing», Vienna, Austria).

Results. During the 8-year monitoring of the microbiota, the urine of patients with recurrent uLUTI was characterized by a microbial pattern certain constancy, but with the predominance (94.1% - 99.1%) of anaerobic-aerobic associations. The antibiotic resistance of most causative and debatable uropathogens increased, and the detection frequency of enterobacteria producing extended-spectrum p-lactamases also increased. Significant differences in the average levels of bacteriuria in the study period for most taxa of microorganisms were not detected.

Conclusion. The detection frequencies of E. coli vary around 50.0%, for other causative pathogens a lower detection rate is noted, while non-clostridial anaerobic bacteria are excreted in 96.6% of cases in patients with recurrent uLUTI. The antibiotic resistance of causative and debatable pathogens and the detection frequencies of enterobacteria producing extended-spectrum p-lactamases are increasing, which necessitates a revision of the etiological structure and approaches to empirical therapy of recurrent uLUTI.

1. Shevyakov M.A. Immunotherapy of infectious and inflammatory diseases of the urinary tract and its effectiveness. Urologia. 2013;2:98-102 (In Russ.). eLIBRARY ID: 19049071

2. Schaeffer AJ, Matulewicz RS, Klumpp DJ. Infections of the Urinary Tract. In Wein AJ, et al, editors, Campbell-Walsh Urology, Eleventh Edition. Philadelphia: Elsevier-Saunders. 2016

3. Guidelines on urological infections. EAU. 2019; 1374.

4. Menshikov V.V. Methods of clinical laboratory research. M.: Lab; 2009: 880. (In Russ.).

5. Clinical recommendations «Bacteriological analysis of urine». M.;2014. (In Russ.).

6. RF patent No. 2452774 «Method for determining bacteriological contamination of urine, prostate secretion, ejaculate» (Bull. No. 16, 2012). Authors: Naboka Y.L., Kogan M.I., Gudima I.A. [and etc.]. (In Russ.).

7. Methodological guidelines 4.2.18990-04 Determination of the sensitivity of microorganisms to antibacterial drugs. M.;2004. (In Russ.).

8. Determination of the sensitivity of microorganisms to antimicrobial agents. Clinical recommendations. Enlarged meeting of the interregional association of microbiology and an-timicrobialchemotherapy (05.22.2015). M.;2015. (In Russ.).

9. Sinyakova, L.A. Recurrent urinary tract infection is a crossdisciplinary problem. Medical advice. 2014;9:100-102. (In Russ.). eLIBRARY ID: 22411056

10. palagin I.S., Sukhorukova M.V., Dehnich A.V., Edelstein M.V., perepanova T.S., Kozlov R.S. The state of antibiotic resistance of causative agents of community-acquired urinary tract infections in Russia, Belarus, and Kazakhstan: the results of the multicenter international study «DARMIS-2018». Urology. 2020;1:19-31. (In Russ.). https://doi.org/10.18565/urology.2020.1.19-31

11. Gill SR, pop M, Deboy RT, Eckburg pB, Turnbaugh RJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett cM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355-9. https://doi.org/10.1126/science.1124234

12. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh c, Nielsen T, pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage p, Bertalan M, Batto JM, Hansen T, Le paslier D, Linneberg A, Nielsen HB, pelletier E, Renault p, Sicheritz-ponten T, Turner K, Zhu H, Yu c, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, pedersen O, parkhill J, Weissenbach J; MetaHIT consortium, Bork p, Ehrlich SD, Wang J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65. https://doi.org/10.1038/nature08821

13. Backhed F, Fraser cM, Ringel Y, Sanders ME, Sartor RB, Sherman pm, Versalovic J, Young V, Finlay BB. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe. 2012;12(5):611-22. https://doi.org/10.1016/jxhom.2012.10.012

14. Rajilić-Stojanović M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014;38(5):996-1047. https://doi.org/10.1111/1574-6976.12075

15. Sekirov I, Russell SL, Antunes Lc, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859-904. https://doi.org/10.1152/physrev.00045.2009

16. Yildirim S, Shoskes D, Kulkarni S, Laguna R Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity? World J Urol. 2020. https://doi.org/10.1007/s00345-020-03099-x

17. Naboka Y.L., Gudima I.A., Dzhalagoniya K.T., chernitskaya M.L., Ivanov S.N. Urine and colon microbiota in patients with recurrent uncomplicated lower urinary tract infection. Urology Herald. 2019;7(2):59-65. (In Russ.) https://doi.org/10.21886/2308-6424-2019-7-2-59-65

18. Mulvey MA, Klumpp D.J., Stapleton A.E. Urinary tract infections: molecular pathogenesis and clinical management. Washington, 2017.

19. philpott H, Gibson p, Thien F. Irritable bowel syndrome -An inflammatory disease involving mast cells. Asia Pac Allergy. 2011;1(1):36-42. https://doi.org/10.5415/apaller-gy.2011.1.1.36

20. Kennedy pJ, cryan JF, Dinan TG, clarke G. Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol. 2014;20(39):14105-25. https://doi.org/10.3748/wjg.v20.i39.14105

21. Turnbaugh pJ, Hamady M, Yatsunenko T, cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480-4. https://doi.org/10.1038/na-ture07540

22. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220-30. https://doi.org/10.1038/nature11550

23. Dore J, Corthier G. Le microbiote intestinal humain [The human intestinal microbiota]. Gastroenterol Clin Biol. 2010;34 Suppl 1:S7-15. French. https://doi.org/10.1016/S0399-8320(10)70015-4

24. Lepage P, Leclerc MC, Joossens M, Mondot S, Blottiere HM, Raes J, Ehrlich D, Dore J. A metagenomic insight into our gut's microbiome. Gut. 2013;62(1):146-58. https://doi.org/10.1136/gutjnl-2011-301805

25. Sitkin S.I., Tkachenko E.I., Vakhitov T.Ya. The phylometabolic core of the microbiota of the intestine. Almanac of clinical medicine. 2015;40:12-34. (In Russ.). eLIBRARY ID: 24210498